Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN

• Published in: International journal of molecular sciences Vol. 18; no. 9; p. 1957
• Main Authors: Chen, Jo-Mei, Fan, Yi-Chin, Lin, Jen-Wei, Chen, Yi-Ying, Hsu, Wei-Li, Chiou, Shyan-Song
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.09.2017; MDPI
• Subjects: Animals; Antiviral Agents - pharmacology; Cattle; Cell Adhesion Molecules - metabolism; Cell Line; Cercopithecus aethiops; Dengue - drug therapy; Dengue fever; Dengue Virus - drug effects; Female; Heparan sulfate; Heparitin Sulfate - metabolism; Humans; Infections; Inhibitory Concentration 50; Lactoferrin - pharmacology; Lectins, C-Type - metabolism; Low density lipoprotein; Mice; Mice, Inbred BALB C; Pregnancy; Receptors, Cell Surface - metabolism; Receptors, LDL - metabolism; Receptors, Virus - drug effects; THP-1 Cells; Vero Cells; Viral infections; Viral Plaque Assay; Virus Attachment - drug effects; heparan sulfate; low-density lipoprotein receptor; DC-SIGN; bovine lactoferrin; dengue virus

Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF signifi...